Quintiles expanding into late-stage research and contract sales with Innovex acquisition.
Executive Summary
QUINTILES TO ADOPT INNOVEX STRATEGY OF LATE-STAGE RESEARCH TO CONTRACT SALES transition following the merger of the two companies, Quintiles CEO Dennis Gillings, PhD, told the UBS health care conference Oct. 7 in New York City. Innovex takes clinical personnel who worked on the last stages of research on a drug and uses them as "ambassadors" to physicians during the launch phase, Gillings explained.